Authors: Upegui-Gonzalez, LC Ly, A Sierzega, M Jarocki, P Trojan, L Duc, HT Pan, YX Shevelev, A Henin, D Anthony, D Nowak, W Popiela, T Trojan, J

Citation: Lc. Upegui-gonzalez et al., IGF-I triple helix strategy in hepatoma treatment, HEP-GASTRO, 48(39), 2001, pp. 660-666

Authors: Upegui-Gonzalez, LC Francois, JC Ly, A Trojan, J

Citation: Lc. Upegui-gonzalez et al., The approach of triple helix formation in control of gene expression and the treatment of tumors expressing IGF-I, ADV EXP MED, 465, 2000, pp. 319-332

Authors: Ly, A Francois, JC Upegui-Gonzalez, LC Swiercz, B Bedel, C Duc, HT Bout, D Trojan, J

Citation: A. Ly et al., Alterations in tumorigenicity of embryonal carcinoma cells by ICF-I triple-helix induced changes in immunogenicity and apoptosis, LIFE SCI, 68(3), 2000, pp. 307-319

Authors: Ait-Si-Ali, S Carlisi, D Ramirez, S Upegui-Gonzalez, LC Duquet, A Robin, P Rudkin, B Harel-Bellan, A Trouche, D

Citation: S. Ait-si-ali et al., Phosphorylation by p44 MAP kinase/ERK1 stimulates CBP histone acetyl transferase activity in vitro, BIOC BIOP R, 262(1), 1999, pp. 157-162